Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
Jaime Signes-Costa, Iván J Núñez-Gil, Joan B Soriano, Ramón Arroyo-Espliguero, Charbel Maroun Eid, Rodolfo Romero, Aitor Uribarri, Inmaculada Fernández-Rozas, Marcos García Aguado, Víctor Manuel Becerra-Muñoz, Jia Huang, Martino Pepe, Enrico Cerrato, Sergio Raposeiras, Adelina Gonzalez, Francisco Franco-Leon, Lin Wang, Emilio Alfonso, Fabrizio Ugo, Juan Fortunato García-Prieto, Gisela Feltes, Mohammad Abumayyaleh, Carolina Espejo-Paeres, Jorge Jativa, Alvaro López Masjuan, Carlos Macaya, Juan A Carbonell Asíns, Vicente Estrada
Archivos de Bronconeumología, doi:10.1016/j.arbres.2020.11.012
Introduction: Patients with pre-existing respiratory diseases in the setting of COVID-19 may have a greater risk of severe complications and even death. Methods: A retrospective, multicenter, cohort study with 5847 COVID-19 patients admitted to hospitals. Patients were separated in two groups, with/without previous lung disease. Evaluation of factors associated with survival and secondary composite end-point such as ICU admission and respiratory support, were explored. Abbreviations: ACE2, angiotensin converting enzyme II; CI, confidence interval; COPD, chronic obstructive pulmonary disease; COVID-19, 2019 novel coronavirus; CQ/HCQ, chloroquine/hydroxychloroquine; FEV1, forced expiratory volume in one second; HFNC, high flow nasal cannula; HOPE-COVID-19, Health Outcome Predictive Evaluation for COVID-19; HR, hazard ratio; ICS, inhaled corticosteroids; ICU, intensive care unit; ILD, interstitial lung disease; IQR, interquartile range; MERS, middle east respiratory syndrome; RT-PCR, real time reverse transcriptase-polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; STROBE, strengthening the reporting of observational studies in epidemiology; WHO, World Health Organization.
Author's contributions JS-C had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis including any adverse effects. JS-C and IJN-G were involved in the design of the study. JBS, JACA were involved in data analysis. All authors were involved in the interpretation of the data and in the writing and critical review of the manuscript.
Conflicts of interest All authors declare no competing interests.
References
Alqahtani, Oyelade, Aldhahir, Alghamdi, Almehmadi et al., Prevalence severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis, PLOS ONE,
doi:10.1001/jama.2020.4326Arentz, Yim, Klaff, Lokhandwala, Riedo et al., Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State, JAMA,
doi:10.1001/jama.2020.4326Bouquet, Tabor, Silver, Nair, Tovchigrechko et al., Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort, Respir Res,
doi:10.1183/13993003.00688-2020Choi, Park, Lee, Suh, Song et al., Effect of asthma and asthma medication on the prognosis of patients with COVID-19, Eur Respir J,
doi:10.1183/13993003.01009-2020Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents,
doi:10.1001/jama.2020.8630Grasselli, Greco, Zanella, Albano, Antonelli et al., Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy, JAMA Intern Med,
doi:10.1371/journal.pone.0233147Guan, Liang, Zhao, Liang, Chen et al., Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis, Eur Respir J,
doi:10.1111/all.14238Lamprecht, Soriano, Studnicka, Kaiser, Vanfleteren et al., Determinants of underdiagnosis of COPD in national and international surveys, Chest,
doi:10.1371/journal.pone.0228544Leung, Yang, Tam, Shaipanich, Hackett et al., ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19, Eur Respir J,
doi:10.1038/s41586-020-2012-7Li, Moore, Vasilieva, Sui, Wong et al., Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus, Nature,
doi:10.1001/jama.2020.6775Lian, Hao, Cai, Zhang, Zheng, Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan, Clin Infect Dis,
doi:10.18632/aging.103000Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA,
doi:10.1001/jama.2020.6775Rosenberg, Dufort, Udo, Wilberschied, Kumar et al., Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State, JAMA,
doi:10.1056/NEJMoa2021436Satia, Cusack, Greene, Byrne, Killian et al., Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma, PLOS ONE,
doi:10.1186/s12931-020-01340-0Soriano, Kendrick, Paulson, Gupta, Abrams et al., Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet Respir Med,
doi:10.1001/jamainternmed.2020.0994Uribarri, Nú Ñez-Gil, Aparisi, Becerra-Mu Ñoz, Feltes et al., Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry, J Nephrol,
doi:10.1183/13993003.00547-2020Von Elm, Altman, Egger, Pocock, Gøtzsche et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet,
doi:10.1001/jamainternmed.2020.3539Wang, Chen, Chen, Liu, Dong et al., Does asthma increase the mortality of patients with COVID-19? A systematic review and meta-analysis, Int Arch Allergy Immunol,
doi:10.1183/13993003.02226-2020Wang, He, Yu, Hu, Bao et al., Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up, J Infect,
doi:10.1016/S0140-6736(07)61602-XWang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA,
doi:10.1056/NEJMoa2002032Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med,
doi:10.1093/cid/ciaa242Yamaya, Nishimura, Deng, Sugawara, Watanabe et al., Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells, Respir Investig,
doi:10.1378/chest.14-2535Zhang, Dong, Cao, Yuan, Yang et al., Clinical characteristics of 140 patients infected with SARS-CoV-2 in, Allergy,
doi:10.1001/jama.2020.1585Zhao, Meng, Kumar, Wu, Huang et al., The impact of COPD and smoking history on the severity of COVID-19: A systemic review and metaanalysis, J Med Virol,
doi:10.1159/000510953Zhou, Yang, Wang, Hu, Zhang et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature,
doi:10.1038/nature02145
